» Articles » PMID: 36450404

Translating Primary Care to Telehealth: Analysis of In-person Consultations on Diabetes and Cardiovascular Disease

Overview
Journal BJGP Open
Specialty Public Health
Date 2022 Nov 30
PMID 36450404
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The COVID-19 pandemic had a considerable impact on primary care, resulting in rapid uptake of telehealth. Patients with chronic conditions, such as type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), relied heavily on telehealth consultations during this period. It is important to assess whether tasks observed during T2DM or CVD in-person consultations are translatable to telehealth.

Aim: To explore the extent to which in-person GP consultations are translatable to telehealth for patients with T2DM or CVD.

Design & Setting: This study screened 281 GP consultations conducted in 2017 within the UK general practice setting for consultations pertaining to T2DM or CVD. Seventeen in-person consultations (in deidentified video and transcript) were selected for further analysis.

Method: Detailed reporting of tasks, physical artefacts, and physical examinations observed during in-person GP consultations. A new scoring method, applying two key metrics, supporting definitions and examples, was designed to assess translatability of clinical tasks to telehealth.

Results: Across the 17 T2DM or CVD in-person consultations analysed, 23 clinical tasks, 21 physical artefacts, and nine physical examinations were observed. Sixty per cent of tasks analysed were deemed either easily or relatively easily translatable to telehealth. Twenty-six per cent of tasks were rated as 'moderately translatable to telehealth' but may require a patient obtaining their own equipment. Thirteen per cent of tasks were rated as 'potentially translatable to telehealth'. No clinical tasks for these cohorts were rated as untranslatable to telehealth.

Conclusion: The majority of tasks observed during T2DM or CVD in-person GP consultations are translatable to telehealth. Further research is warranted to investigate emergent safety concerns from increased uptake of telehealth.

Citing Articles

The BJGP Open Top 10 Most Read Research Articles of 2023: an editorial.

Burrell A, Dambha-Miller H BJGP Open. 2024; 8(1).

PMID: 38418218 PMC: 11169966. DOI: 10.3399/BJGPO.2024.0042.


Analysis of in-person general practice respiratory consultations: assessing translatability to telehealth.

Raghuraman S, Ramarao J, Lane J, Ward K, Lau A BJGP Open. 2023; 7(4).

PMID: 37369520 PMC: 11176680. DOI: 10.3399/BJGPO.2023.0073.

References
1.
de Almeida-Pititto B, Dualib P, Zajdenverg L, Dantas J, de Souza F, Rodacki M . Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr. 2020; 12:75. PMC: 7456786. DOI: 10.1186/s13098-020-00586-4. View

2.
White S, Nguyen A, Roger P, Tse T, Cartmill J, Willcock S . Experiences of telehealth in general practice in Australia: research protocol for a mixed-methods study. BJGP Open. 2021; 6(1). PMC: 8958749. DOI: 10.3399/BJGPO.2021.0187. View

3.
Omboni S, Padwal R, Alessa T, Benczur B, Green B, Hubbard I . The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health. 2022; 1:7-35. PMC: 7612439. DOI: 10.20517/ch.2021.03. View

4.
Taylor A, Caffery L, Gesesew H, King A, Bassal A, Ford K . How Australian Health Care Services Adapted to Telehealth During the COVID-19 Pandemic: A Survey of Telehealth Professionals. Front Public Health. 2021; 9:648009. PMC: 7952432. DOI: 10.3389/fpubh.2021.648009. View

5.
Su D, Zhou J, Kelley M, Michaud T, Siahpush M, Kim J . Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract. 2016; 116:136-48. DOI: 10.1016/j.diabres.2016.04.019. View